APO Research
Talk to an analyst

APO RESEARCH · REPORT

Brand Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Brand Drugs Industry Growth and Trends Forecast to 2032

22 December 2025121 pages

Choose your research edition.

Industry ResearchBrand Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Brand Drugs Industry Growth and Trends Forecast to 2032121 pages · $3,450 USDMarket StructureGlobal Brand Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Brand Drugs Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Brand Drugs Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

According to APO Research, the global Brand Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Brand Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Brand Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Brand Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Brand Drugs market include Takeda, Takeda, Teva, Sanofi, Johnson & Johnson, Novartis, Novo Nordisk, Roche and Eli Lilly, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Brand Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Brand Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Brand Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Brand Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Brand Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Brand Drugs Market by Company

Takeda

Takeda

Teva

Sanofi

Johnson & Johnson

Novartis

Novo Nordisk

Roche

Eli Lilly

Pfizer

GlaxoSmithKline (GSK)

Bayer

Amgen

AbbVie

AbbVie

AstraZeneca

Merck & Co. (MSD)

Gilead Sciences

Bristol-Myers Squibb

Boehringer Ingelheim

Brand Drugs Segment by Type

Biopharmaceutical

Chemistry Medicine

Brand Drugs Segment by Application

Hospital

Clinic

Other

Brand Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Brand Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Brand Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Brand Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Brand Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Brand Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Brand Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Brand Drugs Market Share by Region (2021-2026) Table 4. Global Brand Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Brand Drugs Market Share by Region (2027-2032) Table 6. Global Brand Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Brand Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Brand Drugs Market Size Share by Type (2021-2026) Table 9. Global Brand Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Brand Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Brand Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Brand Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Brand Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Brand Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Brand Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Brand Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Brand Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Brand Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Brand Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Brand Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Brand Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Brand Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Brand Drugs Market Size Share by Application (2021-2026) Table 24. Global Brand Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Brand Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Brand Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Brand Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Brand Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Brand Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Brand Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Brand Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Brand Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Brand Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Brand Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Brand Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Brand Drugs Industry Trends Table 37. Brand Drugs Industry Drivers Table 38. Brand Drugs Industry Opportunities and Challenges Table 39. Brand Drugs Industry Restraints Table 40. Global Brand Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Brand Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Brand Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Brand Drugs Key Company Headquarters & Area Served Table 44. Global Brand Drugs Company, Product Type & Application Table 45. Global Brand Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Brand Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Takeda Company Information Table 49. Takeda Business Overview Table 50. Takeda Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Takeda Brand Drugs Product Portfolio Table 52. Takeda Recent Development Table 53. Takeda Company Information Table 54. Takeda Business Overview Table 55. Takeda Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Takeda Brand Drugs Product Portfolio Table 57. Takeda Recent Development Table 58. Teva Company Information Table 59. Teva Business Overview Table 60. Teva Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Teva Brand Drugs Product Portfolio Table 62. Teva Recent Development Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Sanofi Brand Drugs Product Portfolio Table 67. Sanofi Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Brand Drugs Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Novartis Brand Drugs Product Portfolio Table 77. Novartis Recent Development Table 78. Novo Nordisk Company Information Table 79. Novo Nordisk Business Overview Table 80. Novo Nordisk Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Novo Nordisk Brand Drugs Product Portfolio Table 82. Novo Nordisk Recent Development Table 83. Roche Company Information Table 84. Roche Business Overview Table 85. Roche Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Roche Brand Drugs Product Portfolio Table 87. Roche Recent Development Table 88. Eli Lilly Company Information Table 89. Eli Lilly Business Overview Table 90. Eli Lilly Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Eli Lilly Brand Drugs Product Portfolio Table 92. Eli Lilly Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Pfizer Brand Drugs Product Portfolio Table 97. Pfizer Recent Development Table 98. GlaxoSmithKline (GSK) Company Information Table 99. GlaxoSmithKline (GSK) Business Overview Table 100. GlaxoSmithKline (GSK) Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. GlaxoSmithKline (GSK) Brand Drugs Product Portfolio Table 102. GlaxoSmithKline (GSK) Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bayer Brand Drugs Product Portfolio Table 107. Bayer Recent Development Table 108. Amgen Company Information Table 109. Amgen Business Overview Table 110. Amgen Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. Amgen Brand Drugs Product Portfolio Table 112. Amgen Recent Development Table 113. AbbVie Company Information Table 114. AbbVie Business Overview Table 115. AbbVie Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. AbbVie Brand Drugs Product Portfolio Table 117. AbbVie Recent Development Table 118. AbbVie Company Information Table 119. AbbVie Business Overview Table 120. AbbVie Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. AbbVie Brand Drugs Product Portfolio Table 122. AbbVie Recent Development Table 123. AstraZeneca Company Information Table 124. AstraZeneca Business Overview Table 125. AstraZeneca Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. AstraZeneca Brand Drugs Product Portfolio Table 127. AstraZeneca Recent Development Table 128. Merck & Co. (MSD) Company Information Table 129. Merck & Co. (MSD) Business Overview Table 130. Merck & Co. (MSD) Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 131. Merck & Co. (MSD) Brand Drugs Product Portfolio Table 132. Merck & Co. (MSD) Recent Development Table 133. Gilead Sciences Company Information Table 134. Gilead Sciences Business Overview Table 135. Gilead Sciences Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 136. Gilead Sciences Brand Drugs Product Portfolio Table 137. Gilead Sciences Recent Development Table 138. Bristol-Myers Squibb Company Information Table 139. Bristol-Myers Squibb Business Overview Table 140. Bristol-Myers Squibb Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 141. Bristol-Myers Squibb Brand Drugs Product Portfolio Table 142. Bristol-Myers Squibb Recent Development Table 143. Boehringer Ingelheim Company Information Table 144. Boehringer Ingelheim Business Overview Table 145. Boehringer Ingelheim Brand Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 146. Boehringer Ingelheim Brand Drugs Product Portfolio Table 147. Boehringer Ingelheim Recent Development Table 148. North America Brand Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. North America Brand Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. North America Brand Drugs Market Share by Country (2021-2026) Table 151. North America Brand Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. North America Brand Drugs Market Share Forecast by Country (2027-2032) Table 153. Europe Brand Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 154. Europe Brand Drugs Market Size by Country (2021-2026) & (US$ Million) Table 155. Europe Brand Drugs Market Share by Country (2021-2026) Table 156. Europe Brand Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 157. Europe Brand Drugs Market Share Forecast by Country (2027-2032) Table 158. Asia-Pacific Brand Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 159. Asia-Pacific Brand Drugs Market Size by Country (2021-2026) & (US$ Million) Table 160. Asia-Pacific Brand Drugs Market Share by Country (2021-2026) Table 161. Asia-Pacific Brand Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 162. Asia-Pacific Brand Drugs Market Share Forecast by Country (2027-2032) Table 163. Latin America Brand Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 164. Latin America Brand Drugs Market Size by Country (2021-2026) & (US$ Million) Table 165. Latin America Brand Drugs Market Share by Country (2021-2026) Table 166. Latin America Brand Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 167. Latin America Brand Drugs Market Share Forecast by Country (2027-2032) Table 168. Middle East & Africa Brand Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 169. Middle East & Africa Brand Drugs Market Size by Country (2021-2026) & (US$ Million) Table 170. Middle East & Africa Brand Drugs Market Share by Country (2021-2026) Table 171. Middle East & Africa Brand Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 172. Middle East & Africa Brand Drugs Market Share Forecast by Country (2027-2032) Table 173. Research Programs/Design for This Report Table 174. Authors List of This Report Table 175. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Brand Drugs Product Image Figure 3. Global Brand Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Brand Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Brand Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Brand Drugs Market Share by Region (2021-2032) Figure 7. North America Brand Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Brand Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Brand Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Brand Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Brand Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Biopharmaceutical Image Figure 13. Global Biopharmaceutical Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Chemistry Medicine Image Figure 15. Global Chemistry Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Brand Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Brand Drugs Market Share by Type 2025 VS 2032 Figure 18. North America Brand Drugs Market Size Share by Type (2021-2032) Figure 19. Europe Brand Drugs Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Brand Drugs Market Size Share by Type (2021-2032) Figure 21. Latin America Brand Drugs Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Brand Drugs Market Size Share by Type (2021-2032) Figure 23. Hospital Image Figure 24. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Clinic Image Figure 26. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Other Image Figure 28. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Global Brand Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Brand Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Brand Drugs Market Size Share by Application (2021-2032) Figure 32. Europe Brand Drugs Market Size Share by Application (2021-2032) Figure 33. Asia-Pacific Brand Drugs Market Size Share by Application (2021-2032) Figure 34. Latin America Brand Drugs Market Size Share by Application (2021-2032) Figure 35. Middle East and Africa Brand Drugs Market Size Share by Application (2021-2032) Figure 36. Global Top 5 and 10 Brand Drugs Players Market Share by Revenue in 2025 Figure 37. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 38. North America Brand Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 39. North America Brand Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 40. North America Brand Drugs Market Share by Country (2021-2032) Figure 41. Europe Brand Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. Europe Brand Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Brand Drugs Market Share by Country (2021-2032) Figure 44. Asia-Pacific Brand Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 45. Asia-Pacific Brand Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 46. Asia-Pacific Brand Drugs Market Share by Country (2021-2032) Figure 47. Latin America Brand Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Latin America Brand Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Latin America Brand Drugs Market Share by Country (2021-2032) Figure 50. Middle East & Africa Brand Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 51. Middle East & Africa Brand Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 52. Middle East & Africa Brand Drugs Market Share by Country (2021-2032) Figure 53. Years Considered Figure 54. Research Process Figure 55. Key Executives Interviewed

Scope & coverage.

Types
  • Biopharmaceutical
  • Chemistry Medicine
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Takeda
  • Takeda
  • Teva
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Novo Nordisk
  • Roche
  • Eli Lilly
  • Pfizer
  • GlaxoSmithKline (GSK)
  • Bayer
  • Amgen
  • AbbVie
  • AbbVie
  • AstraZeneca
  • Merck & Co. (MSD)
  • Gilead Sciences
  • Bristol-Myers Squibb
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Brand Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Brand Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Brand Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Brand Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Brand Drugs Market Size (2021-2032)
  8. 1.5.1 North America Brand Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Brand Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Brand Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Brand Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Brand Drugs Market Size Growth Rate (2021-2032)
2 Brand Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Biopharmaceutical
  3. 2.1.2 Chemistry Medicine
  4. 2.2 Global Brand Drugs Market Size by Type
  5. 2.2.1 Global Brand Drugs Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Brand Drugs Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Brand Drugs Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Brand Drugs Market Size by Regions
  9. 2.3.1 North America Brand Drugs Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Brand Drugs Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Brand Drugs Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Brand Drugs Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Brand Drugs Market Size Breakdown by Type (2021-2026)
3 Brand Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Other
  5. 3.2 Global Brand Drugs Market Size by Application
  6. 3.2.1 Global Brand Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Brand Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Brand Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Brand Drugs Market Size by Regions
  10. 3.3.1 North America Brand Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Brand Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Brand Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Brand Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Brand Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Brand Drugs Industry Trends
  2. 4.2 Brand Drugs Industry Drivers
  3. 4.3 Brand Drugs Industry Opportunities and Challenges
  4. 4.4 Brand Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Brand Drugs Revenue (2021-2026)
  2. 5.2 Global Brand Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Brand Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Brand Drugs Company, Product Type & Application
  5. 5.5 Global Brand Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Brand Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Brand Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Brand Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Takeda
  2. 6.1.1 Takeda Company Information
  3. 6.1.2 Takeda Business Overview
  4. 6.1.3 Takeda Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Takeda Brand Drugs Product Portfolio
  6. 6.1.5 Takeda Recent Developments
  7. 6.2 Takeda
  8. 6.2.1 Takeda Company Information
  9. 6.2.2 Takeda Business Overview
  10. 6.2.3 Takeda Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Takeda Brand Drugs Product Portfolio
  12. 6.2.5 Takeda Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Teva Brand Drugs Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Sanofi
  20. 6.4.1 Sanofi Company Information
  21. 6.4.2 Sanofi Business Overview
  22. 6.4.3 Sanofi Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Sanofi Brand Drugs Product Portfolio
  24. 6.4.5 Sanofi Recent Developments
  25. 6.5 Johnson & Johnson
  26. 6.5.1 Johnson & Johnson Company Information
  27. 6.5.2 Johnson & Johnson Business Overview
  28. 6.5.3 Johnson & Johnson Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Johnson & Johnson Brand Drugs Product Portfolio
  30. 6.5.5 Johnson & Johnson Recent Developments
  31. 6.6 Novartis
  32. 6.6.1 Novartis Company Information
  33. 6.6.2 Novartis Business Overview
  34. 6.6.3 Novartis Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Novartis Brand Drugs Product Portfolio
  36. 6.6.5 Novartis Recent Developments
  37. 6.7 Novo Nordisk
  38. 6.7.1 Novo Nordisk Company Information
  39. 6.7.2 Novo Nordisk Business Overview
  40. 6.7.3 Novo Nordisk Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Novo Nordisk Brand Drugs Product Portfolio
  42. 6.7.5 Novo Nordisk Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Roche Brand Drugs Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Eli Lilly
  50. 6.9.1 Eli Lilly Company Information
  51. 6.9.2 Eli Lilly Business Overview
  52. 6.9.3 Eli Lilly Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Eli Lilly Brand Drugs Product Portfolio
  54. 6.9.5 Eli Lilly Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Brand Drugs Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 GlaxoSmithKline (GSK)
  62. 6.11.1 GlaxoSmithKline (GSK) Company Information
  63. 6.11.2 GlaxoSmithKline (GSK) Business Overview
  64. 6.11.3 GlaxoSmithKline (GSK) Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 GlaxoSmithKline (GSK) Brand Drugs Product Portfolio
  66. 6.11.5 GlaxoSmithKline (GSK) Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bayer Brand Drugs Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 Amgen
  74. 6.13.1 Amgen Company Information
  75. 6.13.2 Amgen Business Overview
  76. 6.13.3 Amgen Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 Amgen Brand Drugs Product Portfolio
  78. 6.13.5 Amgen Recent Developments
  79. 6.14 AbbVie
  80. 6.14.1 AbbVie Company Information
  81. 6.14.2 AbbVie Business Overview
  82. 6.14.3 AbbVie Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 AbbVie Brand Drugs Product Portfolio
  84. 6.14.5 AbbVie Recent Developments
  85. 6.15 AbbVie
  86. 6.15.1 AbbVie Company Information
  87. 6.15.2 AbbVie Business Overview
  88. 6.15.3 AbbVie Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 AbbVie Brand Drugs Product Portfolio
  90. 6.15.5 AbbVie Recent Developments
  91. 6.16 AstraZeneca
  92. 6.16.1 AstraZeneca Company Information
  93. 6.16.2 AstraZeneca Business Overview
  94. 6.16.3 AstraZeneca Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 AstraZeneca Brand Drugs Product Portfolio
  96. 6.16.5 AstraZeneca Recent Developments
  97. 6.17 Merck & Co. (MSD)
  98. 6.17.1 Merck & Co. (MSD) Company Information
  99. 6.17.2 Merck & Co. (MSD) Business Overview
  100. 6.17.3 Merck & Co. (MSD) Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  101. 6.17.4 Merck & Co. (MSD) Brand Drugs Product Portfolio
  102. 6.17.5 Merck & Co. (MSD) Recent Developments
  103. 6.18 Gilead Sciences
  104. 6.18.1 Gilead Sciences Company Information
  105. 6.18.2 Gilead Sciences Business Overview
  106. 6.18.3 Gilead Sciences Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  107. 6.18.4 Gilead Sciences Brand Drugs Product Portfolio
  108. 6.18.5 Gilead Sciences Recent Developments
  109. 6.19 Bristol-Myers Squibb
  110. 6.19.1 Bristol-Myers Squibb Company Information
  111. 6.19.2 Bristol-Myers Squibb Business Overview
  112. 6.19.3 Bristol-Myers Squibb Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  113. 6.19.4 Bristol-Myers Squibb Brand Drugs Product Portfolio
  114. 6.19.5 Bristol-Myers Squibb Recent Developments
  115. 6.20 Boehringer Ingelheim
  116. 6.20.1 Boehringer Ingelheim Company Information
  117. 6.20.2 Boehringer Ingelheim Business Overview
  118. 6.20.3 Boehringer Ingelheim Brand Drugs Revenue, Global Share and Gross Margin (2021-2026)
  119. 6.20.4 Boehringer Ingelheim Brand Drugs Product Portfolio
  120. 6.20.5 Boehringer Ingelheim Recent Developments
7 North America
  1. 7.1 North America Brand Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Brand Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Brand Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Brand Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Brand Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Brand Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Brand Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Brand Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Brand Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Brand Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Brand Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Brand Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Brand Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Brand Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Brand Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst